Conference Details - Overview
Continuing Education Information
Physicians: Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians’ Education Resource designates this educational activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The presentation “Ethics” has been designated by Physicians’ Education Resource for 1 hour education in medical ethics and/or professional responsibility.
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA category 1 CME credit for the PRA from organizations accredited by the ACCME.
Practical Updates in Oncology
The Westin Galleria Dallas
Dallas, TX
April 10, 2010
Conference Overview
Overview and Purpose
The Practical Updates in Oncology symposium is designed to educate community physicians on the state-of-the-art clinical management of a wide variety of solid tumors and hematologic malignancies. Lectures will highlight cutting-edge information and emerging treatment strategies for specific tumor types, and there will also be practical, case-based presentation of material. The Ethics presentation will cover key issues in patient communication and shared decision making. This symposium presents an opportunity for continuous dialogue and interaction between academic thought leaders and community oncologists.
Target Audience
This educational program is directed toward medical, surgical, and radiation oncologists and hematologists practicing in the community or academic setting who are interested in recent advances in the treatment of solid tumors and hematologic malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer are also invited to attend.
Learning Objectives
At the conclusion of this symposium, you should be able to:
- Assess the efficacy and safety of targeted agents in the management of patients with solid tumors and hematologic malignancies
- Identify results of recent clinical trials that are applicable to the management of patients with solid tumors and hematologic malignancies
Educational Grants
An educational grant for this activity was provided by:
- Lilly USA, LLC
- Celgene Corporation
- Allos Therapeutics
- Cephalon Oncology
- Millennium Pharmaceuticals, Inc.
- sanofi-aventis U.S.